From K Street to Wall Street
This article was originally published in RPM Report
Executive Summary
The Pharmaceutical Research & Manufacturers of America spends a lot of time lobbying for drug interests and trying to improve the industry's public relations image. But how much of what PhRMA does impacts individual drug company stock prices? The answer, according to top prescription drug analysts, is not much.